23 juillet 2025
14 juillet 2025
تنبيه من المجتمع المدني إعادة تحديد الأولويات البرمجية للمنحة السابعة للصندوق العالمي…
الخلفيةأبلغ الصندوق العالمي لمكافحة الإيدز والسل والملاريا مؤخرًا البلدان بخفض كبير في التمويل المخصص لدورة المنح السابعة (2025–2027)، وأصدر « مظاريف إرشادية » يوم الاثنين 30 يونيو 2025، وهي ميزانيات مؤقتة تُظهر المبالغ المحتملة التي قد تحصل
11 mars 2025
Call for Talents: Transform the Fight against HIV with ADP-MENA (Activists Developmen…
Context: The Middle East and North Africa (MENA) region continues to face major public health challenges related to HIV/AIDS. Key populations, including young people, men who have sex with men, sex workers, and injecting
11 mars 2025
Appel à Talents : Transformez la Lutte contre le VIH avec ADP-MENA
***(Activists Development Program in MENA Region) Contexte : La région du Moyen-Orient et de l’Afrique du Nord (MENA) continue de faire face à des défis majeurs en matière de santé publique liés au VIH/sida. Les
6 mars 2025
TERMS OF REFERENCE FOR AUDIOVISUAL AGENCY FOR GLOBAL SUMMIT 2025
ABOUT ITPC-MENA ITPC-MENA is a regional non-governmental organization operating in the MiddleEast and North Africa region bringing together a network of community activistsunited by our vision of a longer, healthier, more productive life for people
25 novembre 2024
APPEL À CONSULTANT.E
**Titre : Consultant pour Co-Animer un Atelier de Formation Régionale et Rédiger le Rapport Global Contexte : La région du Moyen-Orient et de l’Afrique du Nord (MENA) fait face à des défis majeurs en
22 novembre 2024
Call for Applications for the ADP (Activist Development Program) on HIV and Leadershi…
*Focus only on (Egypt, Lebanon, Morocco, Jordan, and Tunisia). ITPC-MENA is delighted to announce the launch of our HIV and Leadership training program designed for young activists. This program is crafted to enhance the
9 octobre 2024
ViiV HEALTHCARE TO TRIPLE ANNUAL SUPPLY OF LONG-ACTING HIV PREP FOR LOW- AND MIDDLE-I…
Source : ITPC EECA Against the backdrop of a recent press release from Gilead announcing the signing of a voluntary license for the new drug lenacapavir, ViiV Healthcare has announced an increase in the
5 octobre 2024
“Not in Our Name” – African HIV Treatment Advocates React to Gilead’s Voluntary Licen…
Press Statement – 4 October 2024 Today’s announcement by Gilead that six generic manufacturers have been awarded voluntary licenses for the production of lenacapavir—a groundbreaking, twice-yearly injectable for HIV prevention and potential treatment—raises significant concerns
5 octobre 2024